February 8, 2011 – In an announcement by the National Cancer Institute (NCI) and the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for use of a new strength of a previously approved drug, sodium fluoride F 18 (18F-NaF) injection for use in bone scans.

February 9, 2011 — A new study from the Centre for Addiction and Mental Health (CAMH) has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for more than 90% of Alzheimer's cases.

February 7, 2011 – A diverse mix of advanced Vendor Neutral Archive (VNA) installations has been implemented by ScImage. These complex VNA implementations re-define the routine, file storage task of a typical VNA.

February 7, 2011 – Elekta's vendor-neutral Mosaiq Oncology Information System (OIS) has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm.

February 4, 2011 – Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy’s effectiveness, according to research in The Journal of Nuclear Medicine.

February 3, 2011 – Beginning Feb. 7, 2011, the Centers for Medicare and Medicaid Services (CMS) will reimburse sites participating in the National Oncologic PET Registry (NOPR) for F-18 sodium fluoride (NaF) positron emission tomography (PET) scans.

February 1, 2011 – Burton P. Drayer, M.D., has been elected president of the Board of Directors of the Radiological Society of North America (RSNA). His presidency was made official at the 96th Scientific Assembly and Annual Meeting in Chicago.